The reduction of CB1 levels was more evident (to 48%) in tumor cell extracts from animals pre-treated with CBD under PS conditions, indicating that this cannabinoid promotes in the tumor cells the loss of features acquired by exposure to IL-1β. This evidence concerns the gene CNR1 and neoplasm.